Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. exemestane

   Partner Therapeutics Limited

   Breast Cancer

   phase 3 · small molecule · completed

   1 trial →

2. favezelimab/pembrolizumab

   Merck KGaA, Darmstadt, Germany

   Colorectal Cancer

   phase 3 · mab · completed

   1 trial →

3. fianlimab

   Regeneron UK Limited

   Advanced Non-Small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

4. fianlimab

   Regeneron UK Limited

   Non-small Cell Lung Cancer

   phase 3 · small molecule · active

   1 trial →

5. filgrastim

   Hospital Authority, Hong Kong

   Brain and Central Nervous System Tumors

   phase 3 · mab · completed

   2 trials →

6. filgrastim

   Solid Biosciences

   Ovarian Cancer

   phase 3 · mab · completed

   1 trial →

7. filgrastim

   Solid Biosciences

   Lymphoma

   phase 3 · mab · active

   2 trials →

8. filgrastim

   Solid Biosciences

   Lung Cancer

   phase 3 · mab · active

   1 trial →

9. folic acid

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Colorectal Neoplasms

   phase 3 · small molecule · active

   1 trial →

10. furmonertinib 240 mg oral, daily

    ArriVent BioPharma

    Metastatic Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

11. gemcitabine

    NORTHWEST BIOTHERAPEUTICS INC

    Non-Small Cell Lung Cancer

    phase 3 · small molecule · terminated

    1 trial →

12. gemcitabine and cisplatin (Induction chemotherapy)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · active

    1 trial →

13. gemcitabine and cisplatin (Induction chemotherapy)

    Sun Yat-sen University

    Nasopharyngeal Carcinoma

    phase 3 · small molecule · active

    1 trial →

14. gene expression analysis

    United Therapeutics Europe Ltd

    Kidney Cancer

    phase 3 · gene therapy · active

    1 trial →

15. gilteritinib

    Astellas Pharma Inc

    Acute Myeloid Leukemia (AML)

    phase 3 · small molecule · completed

    1 trial →

16. golidocitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T Cell Lymphoma

    phase 3 · small molecule · active

    1 trial →

17. imPaCT-PRO-01

    The George Institute

    Thromboprophylaxis in patients with advanced pancreatic cancer

    phase 3 · small molecule · active

    1 trial →

18. inotuzumab ozogamicin

    Pfizer

    Lymphoma, Follicular

    phase 3 · small molecule · terminated

    1 trial →

19. intensity-modulated radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 · other · active

    1 trial →

20. internal mammary nodal irradiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 3 · other · active

    1 trial →

21. lapatinib

    GlaxoSmithKline

    Neoplasms, Breast

    phase 3 · small molecule · completed

    1 trial →

22. lipegfilgrastim

    Teva Pharma GmbH

    Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia

    phase 3 · small molecule · completed

    1 trial →

23. lomustine

    United Therapeutics Europe Ltd

    Brain and Central Nervous System Tumors

    phase 3 · small molecule · completed

    1 trial →

24. mCapOX plus Cetuximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer (CRC)

    phase 3 · small molecule · active

    1 trial →

25. metformin hydrochloride

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

26. mitomycin C-based hyperthermic intraperitoneal chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 3 · other · active

    1 trial →

27. nab-paclitaxel combined with carboplatin

    The First People's Hospital of Lianyungang

    Epithelial Ovarian Carcinoma Stage III

    phase 3 · small molecule · active

    1 trial →

28. neoadjuvant chemotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Epithelial Ovarian Cancer

    phase 3 · small molecule · active

    1 trial →

29. neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2+ Metastatic Breast Cancer (MBC)

    phase 3 · small molecule · completed

    1 trial →

30. nivolumab

    Bristol-Myers Squibb

    Breast Cancer

    phase 3 · mab · completed

    1 trial →

31. non-pegylated liposomal doxorubicin

    Teva Pharma GmbH

    Tubular Breast Cancer Stage II

    phase 3 · small molecule · completed

    1 trial →

32. novel stent

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Esophageal Cancer

    phase 3 · other · active

    1 trial →

33. obinutuzumab

    Hoffmann-La Roche

    Lymphocytic Leukemia, Chronic

    phase 3 · small molecule · completed

    1 trial →

34. obrixtamig

    Boehringer Ingelheim

    Small Cell Lung Cancer (SCLC)

    phase 3 · small molecule · active

    1 trial →

35. paclitaxel

    United Therapeutics Europe Ltd

    Germ Cell Tumor

    phase 3 · small molecule · active

    1 trial →

36. paclitaxel/anthracycline

    The First People's Hospital of Lianyungang

    Primary Breast Cancer

    phase 3 · small molecule · active

    1 trial →

37. patients undergo cVATS segmentectomy

    The First People's Hospital of Lianyungang

    Non-small Cell Lung Cancer Stage I

    phase 3 · other · active

    1 trial →

38. patients were assigned to receive TNT or iTNT management

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Cancer

    phase 3 · small molecule · active

    1 trial →

39. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 · small molecule · completed

    1 trial →

40. pegfilgrastim

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 3 · mab · active

    1 trial →

41. pembrolizumab

    Merck KGaA, Darmstadt, Germany

    Non-small Cell Lung Cancer

    phase 3 · mab · completed

    2 trials →

42. pembrolizumab/vibostolimab

    Merck KGaA, Darmstadt, Germany

    Carcinoma, Non-Small-Cell Lung

    phase 3 · mab · active

    1 trial →

43. pemetrexed

    Eli Lilly and Company

    Head and Neck Neoplasms

    phase 3 · small molecule · completed

    1 trial →

44. placebo

    Takeda

    Non-cancer Pain

    phase 3 · small molecule · terminated

    1 trial →

45. placebo plus docetaxel

    Boehringer Ingelheim

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · completed

    1 trial →

46. postoperative antimicrobial prophylaxis

    Sun Yat-sen University

    Hepatocellular Carcinoma

    phase 3 · small molecule · on hold

    1 trial →

47. pralatrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Peripheral T-Cell Lymphoma

    phase 3 · small molecule · completed

    1 trial →

48. preoperative short-course radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rectal Neoplasms

    phase 3 · other · terminated

    1 trial →

Frequently asked questions